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The spontaneous transfer of drug resistance genes has been shown to take place between
cultured mammalian NIH-3T3 cells and occurs with a hierarchy of transfer efficiencies,
transformed cells being more efficient than non-transformed cells. This experiment was accom-
plished by co-cultivating two NIH-3T3 sublines, each transfected by standard plasmid methods
with a different drug resistance gene, subjecting the mixed population to double selection by
adding both drugs to the mixed cell culture, and isolating single cells which were resistant to both
drugs. The genes used were the neo gene and gpt gene which conferred resistance to the drugs
G418 and mycophenolic acid, respectively. DNA analysis confirmed the presence of both
resistance genes in the cells which were resistant to both drugs. The mechanism of this gene
transfer was by cell fusion rather than by chromosomal DNA uptake. The efficiency of gene
transfer, as indicated by the number of double-resistant colonies standardized by number ofcells
cultured, was much higher between two sublines ofcells transformed by the EJras oncogene than
between one transformed and one non-transformed subline, which in turn was higher than
between two non-transformed sublines. The higher efficiency of gene transfer between the
transformed cells also occurred when these cells were injected into nude mice, thus demonstrating
that the same process occurred in vivo. It would appear that drug resistance genes may be
transferred spontaneously in cultured mammalian cells by cell fusion, and that transformed cells
have a higher efficiency ofgene transfer compared to non-transformed cells.
INTRODUCTION
The rapid emergence of multiple drug resistance is often observed clinically during
the drug treatment of patients with malignancies. The mechanisms ofdrug resistance
development are poorly understood, though various physiologic, pharmacologic, and
cellular factors are presumably quite important [1]. On the cellular level, the
emergence of drug resistance may be a function of the mutation rate and genetic
instability oftumor cells [2]. Weconsider that cell fusion and the ensuing gene transfer
and subsequent chromosomal segregation may be very important and contribute to the
development of genetic instability in tumors. The increasing genetic instability of a
malignant tumor has been associated with increasing tumor heterogeneity and
metastatic potential [3] and the development ofdrug resistance [2,4].
The observation that clinical drug resistance in human tumors is common and
generally occurs at all tumor sites simultaneously would suggest that either malignant
cells have a great tendency to develop resistance or that the genetic alterations
responsible for resistance can be transferred among malignant cells. A second
hypothesis is that since drug resistance does not routinely appear in normal, non-
malignant tissue, for example, bone marrow, then if gene transfer were to occur, it
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TABLE 1
Drug-Resistant NIH-3T3 Cell Lines
Transformation by
Cell Lines Drug Resistance Gene EJras Oncogene
pEJ103 gpt (mycophenolic acid) Yes
pCV103 gpt (mycophenolic acid) No
pEJ2.9A neo (G418) Yes
pAVCV007 neo (G418) No
would preferentially take place among malignant cells. It has been shown that genes
from pleiotropic drug resistance cells can be placed on the surface of non-resistance
cells and confer on these non-drug-resistance cells the pleiotropic drug resistance
phenotype, supporting the concept ofgenetransfer as an importantcontributing factor
ofthe emergence ofclinical drug resistance [5].
Tostudy the spontaneous transferofdrug resistancegenesfromone mammalian cell
to another, two NIH-3T3 cell lines, each transfected with a different drug resistance
gene, were co-cultivated, and the cell mixture subjected to double selection with both
drugs. Only cells that either contained both drug resistance genes as a result of gene
transfer or shared the needed drug resistance enzymes could survive and grow.
Southern blot analysis [6] ofgenomic DNA from double-resistant cell colonies cloned
from single cells, which were derived from the original double drug-resistant colonies,
was performed to confirm that drug-resistant gene transfer was indeed responsible for
the development ofdouble drug resistance. Comparison ofthe apparent efficiencies of
gene transfer between two sublines of drug-resistant cell lines which had been
transformed by the insertion ofan EJras oncogene was also completed.
METHODS
Cell Culture andEngineering ofCell Lines
Four cell lines (Table 1) were created by introducing the engineered plasmids
depicted in Fig. 1 into mouse fibroblast NIH-3T3 cells by using DNA-calcium
phosphate transfection [7] followed by colony selection with either G418 [8] or
mycophenolic acid [9]. Subclones were passaged weekly without drug, indicating the
stability ofthe integrated resistant genes. All these cell lines were grown in Dulbecco's
Modified Eagle's Medium with 10 percent fetal calfserum, sodium bicarbonate buffer,
penicillin-streptomycin, in 5 percent CO2 at 370C. For the G418 resistant cell lines
(pEJ2.9A and pAVCV007), G418 at 200,ug/ml was added to the medium.
Co-Cultivation ofCell Lines andSelection ofDouble-Resistant Colonies
As single-cell suspensions, each of the two cell lines containing the gpt gene was
mixed with each ofthe twocell lines containing the neo gene (refer to Table 2) and the
cell mixtures seeded to a confluent monolayer density on to 60 mm plates (total of 2 x
106 cells per plate). In some experiments fewer cells were plated, so that drug
treatment could be applied before confluence was achieved. After seven days in
non-selective medium, the cell mixtures were trypsinized into single-cell suspensions
and 5 x 105 cells were seeded on to 100 mm plates (four plates for each cell mixture).
At this cell density, there was very little cell-to-cell contact as determined by
microscopic inspection. Double selection with G418 and mycophenolic acid was then
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FIG. 1. Structure ofplasmids. pAVCV007 is a cosmid vector carrying the neo gene driven by a Rous
sarcoma virus LTR (kindly provided by K.H. Choo and Y.W. Kan). pEJ2.9A is a derivative plasmid with
the 2.9 kb Sac I-Sac I fragment ofthe EJras oncogene which encompasses the entire coding region inserted
into the Bam HI cloning siteofpAVCV007 after Bam linkers were attached to the fragment, immediately 3'
to the EJras insert in the U3 portion of the murine leukemia virus LTR. We have shown that this plasmid
efficiently transforms 3T3 cells upon transfection and expresses the aberrant c-Ha-ras mRNA [Liu E;
unpublished observations]. pCV103 is a cosmid vector which harbors the gpt gene driven by the SV40 early
promoter (a gift of Chris Lau). Its derivative, pEJ103, has the 6.6 kb Bam HI fragment of the EJras gene
inserted into the Bam HI cloning site ofpCV103. pAVCV007 and pCV103 do not transform 3T3 cells upon
transfection, whereas pEJ2.9A and pEJ103 do.
applied to select double-resistant colonies. Care was taken not to dislodge cells during
medium change. After three to four weeks, macroscopically evident colonies (0.5-1.0
mm diameter) werecounted. A separate set ofcell mixtures was subjected to treatment
with polyethylene glycol (PEG), an agent known to enhance cell fusion [10]. The day
following the plating of the cells, a one-minute exposure to a 50 percent w/w
TABLE 2
Spontaneous Gene Transfer as Shown by the Development of Double-Resistant Cell Colonies
Double-Resistant Colonies
Transformed Non-Transformed 1 x 106 Cells
gpt Gene neo Gene gpt Gene neo Gene Spontaneous PEG
pCV103 pAVCV007 0, 1,0 (0.3 ± 0.6) 23 (± 1)
pEJ103 pAVCV007 4, 3,4 (3.7 ± 0.6) 122 (±4)
pEJ2.9A pCV103 3,4,5 (4.0 ± 1.0) 117 (±4)
pEJ103 pEJ2.9A 42, 53, 43, 49 (47 ± 5.2) 148 (±7)
Result of three to four experiments, using two different clones of each of the single-resistant parent cell
lines for each condition. Parentheses indicate mean ± SD. The efficiency ofgene transfer as indicated by
the number of double-resistant colonies was much higher with the two transformed lines than with one
transformed and one non-transformed line, which in turn was higher than with two non-transformed lines




Spontaneous Gene Transfer In Vitro and In Vivo
Cell Mixture lx pEJ103 Double-Resistant Colonies
Condition (Cells Mixed with:) (per 1 x 106 pEJ103 Cells)
1. Monolayer Cell Culture 20x pAVCV007 4
5x PAVCV007 2
1 x pAVCV007 3
1 x pEJ2.9A 42
2. Spheroid Cell Culture 5x pAVCV007 0
1 x pEJ2.9A 38
3. Nude Mice 4x pAVCV007 0
1 x pAVCV007 0
1 x pEJ2.9A 115
pEJ103 cells mixed with pAVCV007 (in various proportions) or pEJ2.9A, with the following experimen-
tal conditions: 1, monolayer cell culture; 2, spheroid cell culture; 3, in vivo in nude mice
PEG-1000 in calcium-free buffer was used. The subsequent methods of double
selection after seven days were the same. Appropriate controls ofsingle drug-resistant
cells and non-drug-resistant cells were performed with all experiments.
Spheroid Cell Culture Experiments
In order to test whether enhanced cell-to-cell contact in a three-dimensional
mixed-cell spheroid system [11] would increase gene transfer, cell mixtures (Table 3,
Condition 2: 5 x 106 pEJ103 cells with 2.5 x I07 pAVCV007 cells or 5 x 106 pEJ2.9A
cells) were placed into 200 ml non-selective medium in spinner bottles. After spheroids
were seen macroscopically (0.5-1.0 mm diameter) in seven to ten days, they were
trypsinized back to single-cell suspensions and 5 x 105 cells were seeded on to 100 mm
plates (four plates for each cell mixture) and double selection was applied, as above.
Nude Mice Experiments
To show that transfer ofdrug resistance genes also occurs in vivo, a mixture of 1 x
106 pEJ103 cells with pAVCV007 or pEJ2.9A cells, as shown in Table 3, Condition 3,
were injected subcutaneously into nude mice. After two weeks, the resultant tumors
were harvested, trypsinized into single-cell suspensions, plated, and subjected to double
selection immediately, as described above. Autopsies on the nude mice revealed no
metastasis.
Southern Blot Analysis ofGenomic DNA
Genomic DNAs from parent NIH-3T3 cells, pAVCV007 cells, pEJ2.9A cells,
pCV103 cells, pEJ103 cells, and seven double-resistant cell lines, as described in the
legend of Fig. 2, were digested with EcoR1, electrophoresed on 0.8 percent agarose
gels, and blotted onto Gene Screen Plus filters. The 0.5 kb Hind III/EcoR1 fragment
from pSV-gpt was nick-translated and used as a probe for the gpt gene; the 0.9 kb Pst I
fragment from pSV2-neo was nick-translated and used as a probe for the neo gene.
Cellular DNA Content Estimate
The relative DNA contents per cell of three double-resistant lines and three
single-resistant parent lines (refer to Table 4) were measured by a fluorescence-
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FIG 2. Southern blot analysis ofgenomic DNA,
usingtheclonedgpt (A, above) and neo (B, below)
genes as probes. Genomic DNAs from parent
3T3 cells, pAVCV007 cells, pEJ2.9A cells,
pCV103 cells, pEJ103 cells, and seven double-
resistant cell lines were analyzed. The double-
resistant cell colonies were from: 1, PEG-treated
pEJ103 and pAVCV007 cell mixture in mono-
layer culture; 2, pEJ103 and pAVCV007 cell
mixture in monolayer culture (spontaneously
developed without PEG treatment); 3, pEJ103
and pEJ2.9A in spheroid culture; 4 and 5, pEJ103
and pEJ2.9A in nude mice; 6 and 7, pEJ103 and
pEJ2.9A in monolayer culture (spontaneously
developed without PEG treatment). A: The
pCV103, pEJ103, and all the double-resistant
cells contained the gpt gene, while the 3T3,
pAVCV007, and pEJ2.9A cells did not. The
pCV103 lane showed one 9 kb band, pEJ103
showed two bands, at 9 kb anad 8.3 kb, indicating
more than one integration site for the gpt gene;
double-resistant colony number 1 showed both the
9 kband the 8.3 kb bands, number 2 the 9 kb band
only, numbers 3 through 7 the 8.3 kb band only.
The loss of one band in double-resistant colonies
numbers 2 through 7, as compared to the parent
pEJ103 cells, suggested that cell fusion was fol-
lowed by chromosome segregation of the fused
cell. B: The pAVCV007, pEJ2.9A, and all the
double-resistant cells contained the neo gene as
shown by the 5 kb band, while the 3T3, pCV103,
and pEJ103 cells did not.
TABLE 4
Relative DNA Contents of Single- and Double-Resistant Cell Lines







From pEJ103 and pAVCV007 in monolayer culture 91
(cells on lane 2 ofSouthern blot analysis)
From pEJ103 and pEJ2.9A in nude mice (lane 4) 103
From pEJ103 and pEJ2.9A in monolayer culture (lane 6) 97













activated cell sorter (Becton Dickinson FACS II), after 70 percent ethanol fixation of
single-cell suspensions of these cell lines (approximately 1 x 106 cells per cubic
centimeter) and labeling the DNA with propidium iodide.
RESULTS
Four cell lines, as listed in Table 1, were created by transfection of NIH-3T3 cells
with four engineered plasmids (pAVCV007, pEJ2.9A, pCV103, pEJ103) and named
according to the plasmid. The structures of the plasmids are depicted in Fig. 1. The
plasmids pAVCV007 and pCV103 confer resistance to G418 and mycophenolic acid,
respectively, whereas pEJ2.9A and pEJ103 are their counterparts, which alsocarry the
transforming EJras oncogene. All cell lines derived from transfecting NIH-3T3 cells
with the above constructs were clonally derived. The pAVCV007 line is resistant to
G418 but is not transformed; the pEJ2.9A line is resistant to G418 and is transformed.
Similarly, the pCV103 line is resistant to mycophenolic acid but not transformed,
while the pEJ103 line is resistant to mycophenolic acid and is transformed. The
advantage of using these drug resistance genes which are of bacterial origin, namely,
the neo gene conferring resistance to G418 and the gpt gene conferring resistance to
mycophenolic acid, is that there are no mammalian genes which could be activated or
mutated to circumvent the toxic actions ofG418 and mycophenolic acid. Only through
gene transfer between the cell lines could some of these cells become resistant to both
drugs and grow under the condition ofdouble selection.
The number of double-resistant colonies from each of the four cell mixtures was
determined and is shown in Table 2. There were 42 to 53 double-resistant colonies per
1 x 106 cells of each cell line when the two transformed lines (pEJ103 and pEJ2.9A)
were used; only three to five double-resistant colonies resulted from one transformed
and one non-transformed line (pCV103 and pEJ2.9A, or pEJ103 andpAVCV007) and
zero to onecolonies from twonon-transformed lines (pCV103 and pAVCV007). These
differences are statistically significant (p < 0.001 by student t-test).
Ifone or both drugs (G418, mycophenolic acid) had been applied before the end of
the seven-day period ofco-cultivation in non-selective medium, the apparent efficiency
of gene transfer decreased (data not shown). If the cell mixture was seeded sparsely
and cell-to-cell contact was never attained (as determined by microscopic examina-
tion) prior to the addition ofboth drugs (selective media), no double-resistant colonies
were obtained. Polyethylene glycol (PEG) also increased the apparent efficiency of
gene transfer (Table 2). It is noteworthy that, for the two transformed cell lines, the
number ofdouble-resistant colonies following the addition of PEG was only increased
threefold, as compared to 30- to 40-fold increase when one transformed and one
non-transformed cell line were used.
Although cell-to-cell contact may be enhanced in a three-dimensional mixed-cell
spheroid system, the apparent efficiency ofgene transfer, represented by the number of
double-resistant colonies, was not higher in the mixed-cell spheroid system as
compared to monolayer growth, as shown in Table 3.
As negative controls, pEJ2.9A and pAVCV007 cells were treated with mycophe-
nolic acid, and pEJ103 and pCV103 were treated with G418. No cell growth oftumor
colonies resulted, although a few scattered pEJ2.9A and pAVCV007 cells remained as
isolated single cells after four weeks.
The doubling times as a measure ofgrowth rate of the cells were as follows: Parent
NIH-3T3 (in non-selective medium)-24 hours; pCV103 (with mycophenolic acid in
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medium)-28 hours; pEJ103 (with mycophenolic acid in medium)-22 hours;
pAVCV007 (with G418 in medium)-24 hours; pEJ2.9A (with G418 in medium)-
22 hours. The double-resistant cells (in double selection medium with G418 and
mycophenolic acid) grow more slowly, with a doubling time between 35 to 44 hours.
In nude mice, 115 double-resistant colonies were obtained from the culture of 2 x
106 tumor cells (i.e., 1 x 106 pEJ2.9A cells) obtained from the tumor which formed at
the injection site of the cell mixture of both transformed lines, pEJ103 and pEJ2.9A.
No double-resistant colonies occurred when the injected cell mixture contained the
transformed pEJ103 and the non-transformed pAVCV007 used instead of the
transformed pEJ2.9A. Thus the same processofdouble drug resistance transfer occurs
in vivo and in vitro with transformed cells showing a higher efficiency compared to
non-transformed cells.
Southern blot analysis of genomic DNA isolated from expanded double-resistant
cell colonies confirmed that the double-resistant cells contained both the neo gene and
thegpt gene. Thus, gene transfer, rather than an epigenetic mechanism, appeared to be
responsible for the double drug resistance (Fig. 2).
The relative DNA content ofthe double-resistant lines is, on the average, 1.65 times
that of the single-resistant parent lines (Table 4) consistent with cell fusion as the
mechanism ofgene sharing in these experiments.
DISCUSSION
The observation that double-resistant cells might result from some form of cell-
to-cell interaction dates back more than 20 years [12]. Onecould not, however, exclude
thepossibility that the single-resistant cells might haveacquired a second resistance by
mutation or gene amplification. Furthermore, an epigenetic phenomenon, rather than
gene transfer, could be the basis of double resistance conferring cell survival. In the
experiments presented, the possibility of mutation or amplification of an endogenous
gene as the basis of double resistance is highly unlikely, since both drug resistance
genes are bacterial in origin, and there are no normal mammalian counterparts.
Southern blot analysis confirmed that gene transfer, rather than an epigenetic
mechanism, was responsible for the double resistance.
Gene transfer between cells may be by cell fusion [13] or uptake of extracellular
chromosomal DNA [14]. Conceivably, one cell may release its DNA into the
microenvironment during its death, and the DNA be taken up by surrounding cells.
Cell fusion was, however, most probably the mechanism ofgene transfer in this study.
The following points support this contention: (1) there was no apparent gene transfer if
the cell mixture was seeded sparsely and cell-to-cell contact did not occur; (2) when
either one ofthe drugs was applied earlier to theco-cultured cells to induce cell necrosis
and DNA release of one cell line, before the second drug was applied, the efficiency of
gene transfer decreased rather than increased (data not shown); (3) the relative DNA
content of the double-resistant lines is 1.65 times that of the single-resistant parent
lines. The number of chromosomes of a fused cell is somewhat less than the sum of
those in the two parent cells, probably due tochromosomesegregation and loss [13,15].
Hybrid cells might be more prone to chromosome rearrangement as compared to their
parent cells [16]. This finding is consistent with cell fusion followed by chromosome
loss. The efficiency ofspontaneous uptake of extracellular chromosomal DNA is quite
low [14]. With uptake of extracellular chromosomal DNA, the overall DNA content
probably would not have increased appreciably.
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Spontaneous cell fusion, in vitro as well as in vivo between injected tumor cells and
host cells, has been well documented [13,15,17]. Cell fusion as part of tumor-tumor
cell interaction has, however, not been well studied. Careful quantification of cell
fusion efficiency comparing transformed cells and non-transformed cells has not been
done.
The apparent efficiency of the transformed cell lines to fuse and form double-
resistant cells approached one per 1 to 2 x 104 cells ofeach cell line. We speculate that
this finding may be important clinically. As an example, let us consider the cancer
patient being treated with two non-cross-resistant drugs (or two drug combinations).
Drug 1 would presumably kill the tumor cells which had not mutated to become
resistant to thisdrug; it would even kill cells thatare resistant todrug 2. Similarly, drug
2 would kill cells, including those resistant to drug 1. This reasoning is behind
combination chemotherapy and non-cross-resistant alternating drug therapy. In a
tumor, however, the cells which are susceptible to both drugs are likely to be killed in
greater proportion than the cells resistant to either drug 1 or drug 2 because there
would be two cytotoxic agents acting concurrently on these doubledrug-sensitive cells.
The proportion of these "single-resistant" cells to either drug 1 or drug 2 would
increase at a time when the entire tumor is shrinking. Eventually a substantial
proportion of the remaining tumor would be composed of these single-resistant cells.
Since the tumor would be smaller because ofthe death ofthe sensitive cells, the single
drug-resistant cells would be more likely to come into cell-to-cell contact with each
other. Ifcell fusion were to occur between cells resistant todrug 1 and cells resistant to
drug 2, then the newly formed fused cells would now be resistant to both drugs and
continue to grow despite treatment with these drugs. This process could be a
mechanism of treatment failure in patients who show a good response initially even to
the point of a clinical "complete remission."
Furthermore, cell fusion with gene transfer and subsequent chromosomal segrega-
tion may contribute to the development of genetic instability in tumors. Goldie and
Coldman have postulated that the emergence of drug resistance may be a function of
the genetic instability of tumor cells [2]. The rate of apparent cellular mutation is
believed to be about one in 106 to 107 cells. The results ofthe experiments presented in
this study show that new genetic material may be acquired through cell fusion with an
apparent efficiency as high as one per 2 x 104 transformed cells. It is conceivable that
this genetransfer results in greater geneticinstability, thus encouraging the emergence
of drug resistance. Certainly these results are not incompatible with the Goldie-
Coldman hypothesis and in fact validate its potential importance.
The observation that transformed cells have a much higher fusion efficiency than
their non-transformed counterparts may be important clinically. This difference may
be due to a difference in the cell membrane properties between malignant and
non-malignant cells [18]. Tumor cell membrane properties have been considered to be
a critical factor in tumor progression and metastasis and in tumor cell heterogeneity
[17,19,20]. Kerbel et al. addressed the fact that there are problems in assessing the
importance of spontaneous in vivo tumor-host cell fusion to tumor progression, tumor
heterogeneity, and metastasis, using lectin-resistant membrane mutants [17,20].
Mutagenesis may induce a variety of genetic changes. In the experiments presented
here, the difference between the cell membranes of the transformed and non-
transformed lines is probably attributable to the action of the EJras oncogene alone
and can thus be more easily studied. Future experiments will attempt to elucidate this
difference biochemically and physiologically.
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It may be argued that since the transformed cells are less anchoraged-dependent,
increase in cell-to-cell contact alone might account for the apparent increase in gene
transfer. This possibility is unlikely, however, because: (1) in the spheroid system,
though cell-to-cell contact was higher, the efficiency of gene transfer was no higher
than that of monolayer; (2) increase in the proportion of the non-transformed
pAVCV007 to the transformed pEJ103 cells, thus increasing the contact of each
pEJ103 cell with the surrounding pAVCV007 cells, did not increase the number of
double-resistant colonies per 1 x 106 pEJ103 cells (Table 3). These observations imply
a qualitative difference between the cell membrane properties of a transformed cell
compared to those ofa non-transformed cell as a potential cause ofthe increased fusion
potential.
Pleiotropic drug resistance to a wide range ofamphiphilic drugs in association with
the development ofa cell surface glycoprotein has been documented [1,21]. This study
described another mechanism that may contribute todrug resistance development, and
that is through the spontaneous gene transfer which may enhance genetic instability,
thus encouraging the development of drug resistance, as well as perhaps directly
affecting the transfer of drug resistance genes among tumor cells. Furthermore, the
much greater efficiency of gene transfer between transformed cells as opposed to
non-transformed cells may help to explain why multiple drug resistance is clinically
observed in tumor cells but not in the normal host cells such as bone marrow cells.
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